Bio-Path Holdings Inc. (BPTH)
NASDAQ
Closed
Sep 4, 2026
Day's Range
0.0100052 wk Range
0.01000Overview - BPTH - Bio-Path Holdings Inc.
Key Statistics
Valuation
Enterprise Value
1.27M
P/E (Trailing)
‪0.36‬
P/E (Forward)
‪-0.0049‬
PEG Ratio
‪-0.0049‬
Price / Book
‪-0.02‬
EV / EBITDA
‪-0.73‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-293.05%‬
Return on Equity
‪-6,424.67%‬
Ownership
Shares Outstanding
9.34M
Float
50.29M
Short % of Shares Outstanding
‪1.38%‬
Held by Insiders
‪0.0030%‬
Held by Institutions
‪0.86%‬
Price stats
Beta
‪-0.49‬
50-Day Avg
‪0.0378‬
200-Day Avg
‪0.0541‬
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BPTH - Bio-Path Holdings Inc.
Peers - BPTH - Bio-Path Holdings Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- BPTHNASDAQBio-Path Holdings Inc.1.50MMarket Cap-266.67%52-week change0.36P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt64.24BMarket Cap+25.70%52-week change40.24P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.35.60BMarket Cap-70.99%52-week change45.79P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE26.05BMarket Cap-8.41%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S17.75BMarket Cap+23.94%52-week change20.58P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.14.63BMarket Cap+27.46%52-week change-19.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.12.87BMarket Cap+15.26%52-week change179.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - BPTH - Bio-Path Holdings Inc.
About
Bio-Path Holdings Inc. is a biotechnology company focused on developing novel cancer therapies through proprietary, cutting-edge technology. Central to Bio-Path’s innovation is its RNAi nanoparticle technology platform, DNAbilize®, which is designed to systemically distribute nucleic acid drugs throughout the body.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
